| Literature DB >> 31098877 |
Rhys E Green1, Deborah J Pain2.
Abstract
It has been known for centuries that lead is toxic to humans. Chronic exposure to lead, even at low levels, is associated with an elevated risk of cardiovascular and chronic kidney disease in adults and of impaired neurodevelopment and subsequent cognitive and behavioural development in the foetus and young children. Health agencies throughout the world have moved from assuming that there are tolerable levels of exposure to lead to a recognition that valid 'no-effect' thresholds cannot currently be defined. Formerly, the most important exposure pathways were occupational exposure, water from lead plumbing, paints, petrol additives and foods. Regulation of products and improved health and safety procedures at work have left dietary lead as the main remaining pathway of exposure in European countries. Ammunition-derived lead is now a significant cause of dietary lead exposure in groups of people who eat wild game meat frequently. These are mostly hunters, shoot employees and their families, but also some people who choose to eat game for ethical, health or other reasons, and their children. Extrapolation from surveys conducted in the UK and a review of studies of game consumption in other countries suggest that approximately 5 million people in the EU may be high-level consumers of lead-shot game meat and that tens of thousands of children in the EU may be consuming game contaminated with ammunition-derived lead frequently enough to cause significant effects on their cognitive development.Entities:
Keywords: Bioavailability; Bullet; Gunshot; Health risk; IQ
Mesh:
Substances:
Year: 2019 PMID: 31098877 PMCID: PMC6675757 DOI: 10.1007/s13280-019-01194-x
Source DB: PubMed Journal: Ambio ISSN: 0044-7447 Impact factor: 5.129
Evidence-based changes in the approach to the evaluation of risks from chronic low-level exposure to lead
| Event | References |
|---|---|
| Public health authorities formerly identified a tolerable rate of dietary intake of lead intended to maintain exposure below an assumed no-observed-adverse-effect-level (NOAEL). An example is the Provisional Tolerable Weekly Intake (PTWI) of lead for infants and children set by the World Health Organization Joint Expert Committee on Food Additives and Contaminants (JECFA) in 1982. The PTWI approach was endorsed by the EU Commission’s Scientific Committee on Food. In the EU, this approach, together with data on lead exposure, resulted in the setting of Maximum Levels of lead in many foodstuffs in the EU Regulation (EC) No 1881/2006 | SCF ( |
| The U.S. Environmental Protection Agency, California EPA and World Health Organization concluded that lead is a substance for which a threshold level for negative effects on human health cannot currently be determined. This rendered the NOAEL and PTWI approaches suspect | USEPA ( |
| The European Commission requested the European Food Safety Authority (EFSA) to produce a scientific opinion on the risks to human health related to the presence of lead in foodstuffs including to consider whether the PTWI of 25 μg/kg b.w. was still appropriate | EFSA ( |
| The EFSA CONTAM Panel identified developmental neurotoxicity in young children and cardiovascular effects and nephrotoxicity in adults as the critical effects for the risk assessment | EFSA ( |
| A meta-analysis of the results of seven studies published between 1989 and 2003 of the IQ of 1333 children in relation to B-Pb, and a refinement/reanalysis of the same data found marked decreases in IQ with increasing B-Pb, even at low B-Pb values. | Lanphear et al. ( |
| Meta-analyses supported a relatively weak, but statistically significant, association between B-Pb levels and systolic blood pressure, amounting to an increase in systolic blood pressure of approximately 1 mmHg with each doubling of B-Pb without any clearly identifiable B-Pb threshold for this effect | Staessen et al. ( EFSA ( |
| A range of cross-sectional and prospective longitudinal studies were conducted to examine the relationship between serum creatinine levels, which rise when kidney filtration is deficient, and B-Pb. Studies suggest an increased likelihood of chronic kidney disease as B-Pb levels rise. EFSA CONTAM Panel concluded that nephrotoxic effects are real, that they may be greater in men than women and that they are exacerbated by concurrent diabetes or hypertension | EFSA ( |
| EFSA ( | EFSA ( |
| Abandonment of NOAEL and PTWI approaches by EFSA was followed by similar conclusions by the WHO/FAO JECFA, Health Canada, and the Centers for Disease Control and Prevention in the United States | JECFA ( |
Daily dietary lead intake values across the EU and lead intake values corresponding to blood lead levels associated with Benchmark Dose Limit reference points for effects on IQ, Systolic Blood Pressure and Chronic Kidney Disease. Taken from EFSA (2010)
| BMDL | Blood lead (µg/L) | Lead intake (µg/kg b.w./d) |
|---|---|---|
| IQ—BMDL01 | 12 | 0.50 |
| SBP—BMDL01 | 36 | 1.50 |
| CKD—BMDL10 | 15 | 0.63 |
| Daily lead intake across EU participating countries µg/kg b.w./d | ||
| Adults, average base diet | 0.36–1.24 | |
| Adults, average base diet with game | 1.98–2.44 | |
| Adults, high base diet | 0.73–2.43 | |
| Children, average base diet | 0.80–3.10 | |
| Children, high base diet | 1.71–5.51 |
The BMDL is the 95th percentile lower confidence limit of the benchmark dose (BMD) of 1% extra risk (BMDL01) used as a reference point for the risk characterisation of lead when assessing the risk of intellectual deficits in children measured by the Full Scale IQ score (1 IQ point reduction) or a 1% increase in systolic blood pressure (SBP). For chronic kidney disease, the BMDL10 represents a 10% increase in prevalence